Gmt Capital Corp Ocugen, Inc. Call Options Transaction History
Gmt Capital Corp
- $2.45 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
125Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$14.4 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$13.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$5.34 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY2.35MShares$2 Million0.82% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $184M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...